Although the greater expression levels of STC1 in tumor samples could be interpreted as its pro-oncogenic role in tumor progression, the counteracting effects STC1 on the pro-inflammatory effects of IL6 and IL8 might slow down the process of carcinogenesis. Here, IL6 is linked to neoplasm.